Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04831580 · ClinicalTrials.gov registry record · NA
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
A NA study of Cervical Cancer, sponsored by GOG Foundation.
- Recruiting
- Registry status
- NA
- Development phase
- 840
- Enrollment target
- 20
- Study locations
NCT04831580: Recruiting NA study of Cervical Cancer, sponsored by GOG Foundation.
NCT04831580 is a NA study of Cervical Cancer that is actively recruiting participants, run by GOG Foundation. The registered enrollment target is 840 participants, above the 565-participant average among 144 other Cervical Cancer trials with a reported enrollment target (49% higher). The trial reports 20 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04831580, a NA study of Cervical Cancer, is actively recruiting participants, sponsored by GOG Foundation.
- RECRUITING
- Registry status
- NA
- Development phase
- 840 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a randomized controlled trial to compare survival for patients who undergoe robotic assisted laparoscopy versus open hysterectomy and lymph node assessment for the treatment of early stage cervical cancer.
Primary Outcome
3 year disease-free survival
Conditions Studied
Interventions
- DEVICE da Vinci
- OTHER open surgery
Study Locations (20)
California
- City of Hope - Duarte
- University of California San Diego Medical Center - Encinitas
- City of Hope Orange County Lennar Foundation Cancer - Irvine
- University of California San Diego Medical Center - La Jolla
- University of California San Diego Moores Cancer Center - La Jolla
- Hoag Gynecologic Oncology - Newport Beach
- Hoag Memorial Hospital Presbyterian - Newport Beach
- Palo Alto Medical Foundation - Palo Alto
- Stanford Hospital - Palo Alto
- University of California San Diego Medical Center - San Diego
- California Pacific Medical Center-Research Institute - San Francisco
- City of Hope - Upland - Upland
- University of California San Diego Medical Center - Vista
Connecticut
- Hartford Healthcare Cancer Institute at Hartford Hospital - Hartford
- Hartford Hospital - Hatford
- Hartford Healthcare Medical Group-Manchester - Manchester
- Harford HealthCare Cancer Institute at the Hospital of Central Connecticut - New Britain
Florida
- Ascension Medical Group St. Vincent's Obstetrics and Gynecology - Jacksonville
- Mercy Hospital - Miami
Arizona
- Western Regional Medical Center LLC - Goodyear
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 840 participants |
| Start Date | 2022-03-22 |
| Est. Completion | 2029-08 |
| Phase | NA |
What NCT04831580 shows while recruiting
NCT04831580 is an interventional study that assigns participants to a tested intervention. The registered 840 participants enrollment target is mid-sized for trials with a published cap, above the 565-participant average among 144 other Cervical Cancer trials with a reported enrollment target (49% higher).
The record links to 1 condition, with Cervical Cancer appearing as the primary indexed condition, and to 2 interventions - of which da Vinci is the first listed.
NCT04831580 names 20 study sites across 4 states, led by California, Connecticut, Florida.
Frequently Asked Questions
What is clinical trial NCT04831580 about?
NCT04831580 is a clinical study titled "A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer". This is a randomized controlled trial to compare survival for patients who undergoe robotic assisted laparoscopy versus open hysterectomy and lymph node assessment for the treatment of early stage cervical cancer.
What is the current status of trial NCT04831580?
This trial is currently recruiting. It is a NA study. The enrollment target is 840 participants. The study started on 2022-03-22. Estimated completion is 2029-08.
What conditions does trial NCT04831580 study?
This clinical trial studies the following conditions: Cervical Cancer.
What interventions are being tested in trial NCT04831580?
The interventions under investigation include: da Vinci (DEVICE), open surgery (OTHER).
Who is sponsoring clinical trial NCT04831580?
This trial is sponsored by GOG Foundation, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04831580 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04831580's enrollment target sits among peer trials
840 18th of 144 higher than 126 of 144 other Cervical Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cervical Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04976881 · 840 participants · NA
Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes
- NCT04985903 · 840 participants · NA
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
- NCT05384626 · 840 participants · Phase 1
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- NCT06197997 · 840 participants · NA
Resilient, Engaged, and Connected Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI